By using iPSC-induced ROs from patient-derived RB1 mutations as a disease model, the study demonstrated that pRB-depleted retinal organoids displayed characteristics resembling those of Rb tumors, including mitochondrial ridge aberrations and rose-like structures, and were capable of cell transformation in vitro. The gene discussed is RB1; the disease is retinoblastoma.